RESECTABLE HEPATOCELLULAR CARCINOMA
Clinical trials for RESECTABLE HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for RESECTABLE HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo attack on liver cancer before surgery
Disease control Recruiting nowThis early-stage study is testing whether adding targeted radiation to two immunotherapy drugs is safe and tolerable for people with operable liver cancer. The goal is to shrink tumors before surgery to improve outcomes. About 20 participants will receive either the two drugs alo…
Matched conditions: RESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: Jiping Wang, MD, PhD • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
New scan aims to sharpen the picture of liver cancer
Diagnosis Recruiting nowThis study is testing a new type of PET scan that uses a special tracer called 18F-FSPG. The goal is to see if this scan can better find and map out liver cancer in patients who are scheduled for surgery or a liver transplant. Researchers will compare this new scan to current sta…
Matched conditions: RESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Mar 30, 2026 14:29 UTC